Recruiting strategies will need to continue evolving as the work demographic shifts and technology advances, but traditional companies may struggle to attract the best talent available. […]
Female CEOs remain exceedingly rare in the drug industry, accounting for less than 10% of biotech’s top leaders. A recent BioPharma Dive analysis of 180 leading […]
Regeneron is investing $800M in its New York operations to keep up with the growth of its flagship eye med Eylea and fast-launching immunology drug Dupixent. […]
In a race for its initial gene therapies, Pfizer is injecting another $500M into a manufacturing plant in North Carolina and plans to hire another 300 […]
Here, FiercePharma has ranked the top 10 biopharma companies by median employee pay in 2018. Most of the companies listed have fewer products and employees than […]
Once again, FierceBiotech has honored a group of hard working and cutting-edge biotech companies with their Fierce 15 award. This year they’ve looked outside the U.S. […]
Novartis announced a five-year partnership with Microsoft in a bet that the tech company can help it make better sense of the data they generate from […]